1. Home
  2. KRO vs LBRX Comparison

KRO vs LBRX Comparison

Compare KRO & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$5.43

Market Cap

602.9M

Sector

Industrials

ML Signal

HOLD

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$23.49

Market Cap

602.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRO
LBRX
Founded
1916
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.9M
602.6M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
KRO
LBRX
Price
$5.43
$23.49
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
2
3
Target Price
$6.00
$49.00
AVG Volume (30 Days)
307.8K
224.2K
Earning Date
03-09-2026
05-09-2026
Dividend Yield
3.62%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,859,400,000.00
N/A
Revenue This Year
$3.47
N/A
Revenue Next Year
$11.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$13.40
52 Week High
$7.94
$27.55

Technical Indicators

Market Signals
Indicator
KRO
LBRX
Relative Strength Index (RSI) 47.90 47.32
Support Level $5.14 $22.34
Resistance Level $5.85 $24.70
Average True Range (ATR) 0.32 1.30
MACD 0.00 -0.18
Stochastic Oscillator 51.14 20.20

Price Performance

Historical Comparison
KRO
LBRX

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.

Share on Social Networks: